- Report
- May 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Report
- May 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
The Undifferentiated Cell market is a subset of the Stem Cell market, which focuses on the use of undifferentiated cells for medical treatments. Undifferentiated cells are cells that have not yet developed into a specific type of cell, such as a muscle cell or a nerve cell. These cells are capable of self-renewal and can be used to create a variety of different cell types. They are used in regenerative medicine, tissue engineering, and drug discovery.
Undifferentiated cells are typically sourced from embryonic stem cells, adult stem cells, or induced pluripotent stem cells. These cells are then cultured in a laboratory setting and manipulated to create the desired cell type.
Companies in the Undifferentiated Cell market include Cellular Dynamics International, Pluristem Therapeutics, and Osiris Therapeutics. These companies specialize in the development and production of undifferentiated cells for medical treatments. Show Less Read more